郑伟鹤于2026年8月20日以每股均价4.3369港元卖出银诺医药-B股份112.00万股,涉资约485.73万港元。
郑伟鹤此次减持前持有银诺医药-B好仓3861.11万股,占比9.19%;减持后持股量为3749.11万股,好仓比例降至8.92%。
郑伟鹤于2026年8月20日以每股均价4.3369港元卖出银诺医药-B股份112.00万股,涉资约485.73万港元。
郑伟鹤此次减持前持有银诺医药-B好仓3861.11万股,占比9.19%;减持后持股量为3749.11万股,好仓比例降至8.92%。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.